Welcome to CNUS Appbeplay 主页 | 中文版
Home>News Content
No. 164 Heze Enzyme Degradation Preparing Low Molecular Heparin Industrial Production Project
I. Project name
Heze Enzyme Degradation Preparing Low Molecular Heparin Industrial Production Project
II. Brief introduction of project unit
Shandong Shenlian Biologic Technology Co., Ltd. is located in
III. Project contents and construction capacity
The project uses “fusion heparinase and heparinase to produce low molecular heparin technology”, and builds factory building and equipment required by 400 billion unit/year low molecular heparin sodium project.
IV. Project construction conditions
Low molecular heparin sodium is new generation of heparin type anti-thrombotic drug developed in recent ten years. Heparin has strong anticoagulant effect, is the first first selective drug for preventing thromboembolic disease caused by deep vein thrombosis, etc, and has several biologic effects such as anti-inflammatory, antiallergic, antivirus and anticancer.
V. Total project investment
USD 20 million
VI. Analysis and prediction of market and economic benefits
After the project is put into production completely, it can realize annual sales income of RMB 410 million, exporting amount of USD 25 million, total investment profit rate of 15.2%, financial internal rate of return of 16.8% and static payback period (including construction period) of 6.8 years.
VII. Cooperation form
Solely foreign funded, joint venture, cooperative operation.
VIII. Contact information
Address: Heze Commercial Bureau
Contact: Tian Zhongtian
Postcode: 274000
Telephone: +86-530-6220275
Email: 5336400@163.com
No. 165 Heze 80 Million Set/year Drug (Drug Foil) Packing Project
I. Project name
Heze 80 Million Set/year Drug (Drug Foil) Packing Project
II. Brief introduction of project unit
Heze Wanxing Drug Packing Co., Ltd, is located in
III. Project contents and construction capacity
The project purchases 2 new drug packing material production lines, and builds 80 million set/year drug (drug foil) packing production line and relevant facilities.
IV. Project construction conditions
The company obtains a batch of know-hows and patent technologies. With continuous development and innovation of technology, drug packing forms change continuously, polyethylene bottle, polypropylene bottle, polymer bottle, aluminum plastic packing, strip packing and strip complex film will become popular types of solid form drug packing.
V. Total project investment
USD 25 million
VI. Analysis and prediction of market and economic benefits
After the project is put into production completely, it can realize annual sales income of RMB 1 billion, profit and tax of 120 million, investment payback period of 4.8 years, investment profit rate of 25.78% and static payback period of 5.1 years.
VII. Cooperation form
Solely foreign funded, joint venture.
VIII. Contact information
Address: Heze Commercial Bureau
Contact: Tian Zhongtian
Postcode: 274000
Telephone: +86-530-6220275
Email: 5336400@163.com
No. 166 Heze Dicloxacillin Sodium, Flucloxacillin Sodium and Tazobactam Sodium Production Project
I. Project name
Heze Dicloxacillin Sodium, Flucloxacillin Sodium and Tazobactam Sodium Production Project
II. Brief introduction of project unit
Shandong Bairui Pharmaceutical Co., Ltd. is production base of APIs of semi-synthetic antibiotics, which integrates research, development, pilot-scale experiment, production and trade. It mainly produces oxacillin sodium, cloxacillin sodium, sulbactam sodium, azlocillin sodium, mezlocillin sodium and amoxicillin sodium, and has annual semi-synthetic penicillin raw medicine of 150 tons.
III. Project contents and construction capacity
According to the needs of foreign and domestic markets, developed products such as oxacillin sodium, cloxacillin sodium, sulbactam sodium, azlocillin sodium, mezlocillin sodium and amoxicillin sodium form scale product, and obtain good economic benefit, and various products such as ticarcillin sodium and amitriptyline sodium can’t form scale temporarily due to limit of production capacity.
IV. Project construction conditions
The company owns core production technologies of semi-synthetic antibiotics. It obtains drug approval numbers of 8 sterile APIs, and all products pass national GMP authentication. The products use solvent crystallization, and have good crystal shape, high purity and low emission.
V. Total project investment
USD 35 million
VI. Analysis and prediction of market and economic benefits
After project reaches its design capacity, it can realize annual business income of RMB 480 million and total profit of RMB 65 million.
VII. Cooperation form
Joint venture, cooperative operation.
VIII. Contact information
Address: Heze Commercial Bureau
Contact: Tian Zhongtian
Postcode: 274000
Telephone: +86-530-6220275
Email: 5336400@163.com
No. 167 Jining Yulong Drug Park Chemical Drug Project
I. Project name
II. Brief introduction of project unit
Shandong Kongfu Pharmaceutical Co., Ltd. is under Shandong Yulong Mine Group, is a modern traditional Chinese medicine pharmaceutical enterprise, and has total assets of RMB 80 million.
III. Project contents and construction capacity
1. Project contents: It is planning to introduce funds and new chemical drugs, and to build chemical drug industrial base. 2. Construction capacity: The project has floor area of 400 mu.
IV. Project construction conditions
The production line passes national drug GMP authentication, uses traditional Chinese medicine as leading, and owns 7 dosage forms and 35 types, i.e., oral liquid, syrups, granule, tablet, capsule, pill and powder.
V. Total project investment
USD 130 million
VI. Analysis and prediction of market and economic benefits
After the project is put into production completely, it can realize annual new sales income of USD 160 million and profit of USD 50 million.
VII. Cooperation form
Joint venture, solely foreign funded, cooperative operation.
VIII. Contact information
Address: Qufu Commercial Bureau,
Contact: Liu Qiaoya
Postcode: 273100
Telephone: +86-537-4498623
Email: qfsswj@126.com
No. 168 Liaocheng Hide Glue Industrial Park Project
I. Project name
II. Brief introduction of project unit
III. Project contents and construction capacity
The project bases on traditional hide glue brand advantage, introduces hide glue series product and health product enterprises, extends industrial chain, improves industrial added value, and makes great efforts in comprehensive, high grade and large production base of various products such as Chinese patent drug, health food, health care cosmetic and donkey meat.
IV. Project construction conditions
Dong’e is “town of hide glue”, “good place for health maintenance”, glue and health care production enterprises are famous in China, its hide glue output and exporting quantity take over 75% and 90% of the whole country respectively, and Dong’e becomes new nutrition and health product industrial base.
V. Total project investment
USD 350 million
VI. Analysis and prediction of market and economic benefits
After project reaches its design capacity, it can realize annual sales income of USD 1.2 billion.
VII. Cooperation form
Joint venture, cooperative operation.
VIII. Contact information
Address: No. 116,
Contact: Chen Shuguang
Postcode: 252201
Telephone: +86-635-3289072
Email: desw0635@163.com
No. 169 Liaocheng Bioactive Polypeptide Agent Production Project
I. Project name
Liaocheng Bioactive Polypeptide Agent Production Project
II. Brief introduction of project unit
Shandong Shenxian Jinxing Livestock and Poultry Co., Ltd, established in 2003, is located in Liaocheng Luxi Economic Development Area. The company integrates breeding poultry, incubation, forage, breeding and processing, has main products such as plain chicken, eviscerated chicken, conditioning chicken, cooked food and string type food, sells its products to large and middle cities such as Guangzhou, Shenzhen, Shanghai, Beijing and Tianjin, and realizes annual sales volume of over RMB 500 million.
III. Project contents and construction capacity
The project introduces production line to realize 600 ton/year bioactive polypeptide agent.
IV. Project construction conditions
Bioactive polypeptide agent is mainly used for curing and preventing various poultry diseases. Shenxian County is large animal husbandry county and town of China small meat chicken, and has 600 million piece/year meat chicken; surrounding farming animal husbandry develops quickly. Demand on bioactive polypeptide agent is large, and market prospect is wide.
V. Total project investment
USD 25 million
VI. Analysis and prediction of market and economic benefits
After project reaches its design capacity, it can realize annual sales income of RMB 240 million, profit and tax of RMB 72 million, including profit of RMB 57 million.
VII. Cooperation form
Joint venture, cooperative operation.
VIII. Contact information
Address: East end, Liaocheng Luxi Economic Development Area.
Contact: Wang Zhijie
Postcode: 252400
Telephone: +86-13906357436
Email: mfjyxk66@163.com
No. 170 Qingdao Life Technology Industry Investment Promotion Project
I. Project name
Qingdao Life Technology Industry Investment Promotion Project
II. Brief introduction of project unit
Planning area of life technology industry gathering area is between Huashan Third Road in the east, Qingyin Expressway and Weiqing Expressway in the west,
III. Project contents and construction capacity
The project will be built into new high grade industry gathering area, which uses biologic and medical engineering products such as high-tech medical equipment and medical material as basis, and includes biologic and medical relevant industries such as biologic technology drug and diagnosis agent.
IV. Project construction conditions
The first stage of Toray project - haemodialysis machine entered trial production, and the second stage - artificial kidney project built factory building of
V. Total project investment
USD 500 million
VI. Analysis and prediction of market and economic benefits
Staying projects in life technology industry gathering area include Japan Toray haemodialysis machine project, microbial oil and baby milk formula project, Switzerland helico-centrifugal pump project, Japan hydrogen essence water equipment project, etc.
VII. Cooperation form
Solely foreign funded, joint venture.
VIII. Contact information
Address: Jimo City, Shandong Province
Contact: Zhou Shaoxia
Postcode: 266000
Telephone: +86-532-88556506
Email: jimoswj@126.com
No. 171 Weihai Marine Bioactive Extract, American Ginseng Extract and Pectin Production Project
I. Project name
Weihai Marine Bioactive Extract, American Ginseng Extract and Pectin Production Project
II. Brief introduction of project unit
Weihai Huayang Drug Co., Ltd., established in 1992, is modern pharmaceutical enterprise that integrates scientific research, production and marketing. It has plant area of
III. Project contents and construction capacity
1. It introduces drug and food high production technologies, including but not limit to marine bioactive extract production, pectin production, American ginseng extract, etc. 2. It wants to make market cooperate with foreign and domestic specialized factories, and to expand new international and domestic markets by existing production technology and equipment.
IV. Project construction conditions
Weihai Huayang Drug Co., Ltd., has 19 agent types with approval numbers and GMP authentication, and owns advanced production equipments. Wendeng City is abundant in various marine products, is important production base of Chinese apple and American ginseng, and provides the most favorable raw material and production conditions for project implementation.
V. Total project investment
USD 30 million
VI. Analysis and prediction of market and economic benefits
After the project is put into production completely, it can realize annual new sales income of RMB 300 million and profit of RMB 50 million.
VII. Cooperation form
Joint venture, technical cooperative operation, trade cooperative operation.
VIII. Contact information
Address: Wendeng Commercial Bureau
Contact: Li Zongwen
Postcode: 264400
Telephone: +86-631-8456416
Email: wdwzgl@163.com
No. 172 Zaozhuang Chiral Agent Construction Project
I. Project name
Zaozhuang Chiral Agent Construction Project
II. Brief introduction of project unit
Zaozhuang Baike Drug Co., Ltd, established in 1976, is pharmaceutical enterprise with long history in Zaozhuang City, has factory area of 105 mu, and owns workshops and office area of
III. Project contents and construction capacity
The project has factory area of 105 mu, workshops and office area of
IV. Project construction conditions
The project is handling preliminary procedures such as establishment and environmental protection, and is now building factory building.
V. Total project investment
USD 98.82 million
VI. Analysis and prediction of market and economic benefits
After the project is put into production completely, it can realize annual new sales income of RMB 2 billion and profit of RMB 450 million.
VII. Cooperation form
Joint venture, cooperative operation.
VIII. Contact information
Address: North side, Shengong Road, Zaozhuang High-tech Area
Contact: Chen Fanjie
Postcode: 277800
Telephone: +86-632-2989678
Email: fanjie.chen@viwit.com
No.173 Jinan's High and New Technology Development Zone Medicine Valley Industrial Park
I. Project Name
Jinan's High and New Technology Development Zone Medicine Valley Industrial Park
II. Project Overview
At state-level, Jinan High and New Technology Development Zone consists of three zone of central zone (
III. Investment Environment
Now, the 33-storey research building for two projects of national comprehensive new drug research platform and national innovation medicine incubation base has finished its civil work. After completion, it will accommodate more than 300 firms and become a core carrier of new drug research and development in Shandong Province.
IV. Cooperation Fields and Direction
Jinan High and New Technology Development Zone is to build a 10,000-mu biotic medicine industrial park in Suncun, to receive big platform achievement industrialization projects. There will be small and medium-sized enterprise expansion zone and big enterprise zone. The small and medium-sized enterprise expansion zone will includes biotic medicine production zone, chemical medicine production zone, traditional Chinese medicine and natural medicine production zone, and medical appliance production zone.
V. Cooperation Form
Joint venture, cooperative operation or solely foreign funded.
VI. Contact Information
Phone: 0086-531-66607160
Email: jn66607160@163.com
Fax: 0531-66607160
Address: Fl. 8 Block D, Long'ao Building, No. 1 Longding Avenue, Lixia District, Jinan, Shandong
Postcode: 250099
No.174 Yantai High and New Technology Development Zone International Biotic Technical Park
I. Project Name
Yantai High and New Technology Development Zone International Biotic Technical Park
II. Project Overview
Yantai High and New Technology Development Zone International Biotic Technical Park is invested jointly by Yantai High and New Technology Development Zone and Shandong Green Leaf Pharmacy Group Co. Ltd. and constructed and operated by Shandong International Biotic Technical Park Development Co. Ltd.. Yantai High and New Technology Development Zone International Biotic Technical Park has been listed in national new drug research and development platform, as an important part of Shandong's important new drug development center. After completion of the project, it will create an innovative biotic technical research and development base first class in China and well known in the world.
III. Investment Environment
The Phase 1 has been initiated to build 5 scientific research buildings and 10 entrepreneur incubation buildings. The initiation building has been put into use and the other buildings completed and put into operation in the later half of 2014.
IV. Cooperation Fields and Direction
Push forward the incubation and industrialization of biotic medicine, marine biotic, biotic agriculture, health medical service and other high-end industries.
V. Cooperation Form
Joint venture, cooperative operation
VI. Contact Information
Contact: Li Zheng
Phone and fax: 0086-535-3800888
Email: Bioasis@luye.cn
No.175 Yantai Development Zone Biotic Medicine Industrial Park
I. Project Name
Yantai Development Zone Biotic Medicine Industrial Park
II. Project Overview
Established in 1984 as approved by the State Council, Yantai Economic and Technical Development Zone is one of the first batch 14 state-level development zones. In 2012, it realized GDP of RMB 100 billion, local fiscal revenue of RMB 4.66 billion and import/export of USD 27 billion. Yantai Economic and Technical Development Zone has Shandong Simcere Pharmacy, New Age Health Industry and other famous medicine and health product manufacturers.
III. Cooperation Fields and Direction
Biotic medicine and healthy nutritional food industries.
IV. Total Investment
USD 300 million
V. Cooperation Form
Joint venture, solely foreign funded
VI. Contact Information
Contact: Ji Yongqiang
Phone and fax: 0086-535-6396705
Email: kfq6396697@163.com
No.176 Jiaxiang Economic Development Zone Biotic Industrial Park
I. Project Name
Jiaxiang Economic Development Zone Biotic Industrial Park
II. Project Overview
As a park special for biotic medicine industry, it is oriented to biotic medicine, biotic manufacturing, biological energy, biotic environment protection and biotic service.
III. Investment Environment
The park is located in Jiaxiang Economic Development Zone, with good conditions and convenient communications to receive projects.
IV. Cooperation Fields and Direction
Towards biotic industries, the park introduces high-tech, high added value firms.
V. Cooperation Form
Joint venture, cooperative operation or solely foreign funded.
VI. Contact Information
Phone: 13792392520
Email: jxxlgjjq@163.com
Address: Jiaxiang Economic Development Zone, Jiaxiang County
No. 17710 billion donkey-hide gelatin biotechnology industry project of Dong-E Economic Development Zone
I. Project name
10 billion donkey-hide gelatin biotechnology industry project of Dong-E Economic Development Zone
II. Briefings of project unit
Dong-E is a national important production base of donkey-hide gelatin and donkey-hide gelatin products. Shandong DEEJ Co., Ltd. is a national leading enterprise with output and export volume of donkey-hide gelatin respectively accounting for more than 75% and 90% of total amount. Currently, Dong-E has already became a newly emerging dietary supplement industrial base and health maintenance, leisure and tourism destination.
III. Project contents and construction capacity
Donkey-hide gelatin biotechnology industry project is located in Dong-E Economic Development Zone and covers an area of more than 1,000 mu with construction area of 500,000 m2. The project is divided into two phases. Phase I mainly focuses the construction of workshop, logistics warehouse and other facilities with construction area of 167,000 m2and purchases advanced production facilities and laboratory apparatus with annual output of 150,000 tons of donkey-hide gelatin and donkey-hide gelatin products. Phase II focuses on the construction of donkey industry research institute, national gelatins traditional Chinese medicine engineering research center, biotechnology research laboratory and 5A sight-seeing tour zone to promote R&D and production of new genetic engineering drugs, drive on industrialization and internationalization progress of biopharmaceutical industry and create a large national comprehensive drug R&D technical platform. After completion, Dong-E will form four industrial bases of donkey-hide gelatin and traditional Chinese medicine, aesthetic health care, ass meat processing and biopharmaceutical industries and a national 5A industrial tourism area.
IV. Total investment
USD 1644.437 million
V. Market forecast and analysis
After being put into operation, the project is planning to realize annual sales revenue of 14.5 billion Yuan and profits of 2.35 billion Yuan.
VI. Way of cooperation
Joint venture and cooperative operation
VII. Contact information
Contact person: Cui Qingshen 0086-635-3261817
Telephone& Fax: 0086-635-3261817 E-mail: lcjmwz@163.com
No. 178 Biological medicine industrialization base construction project of Shandong Shennuoji Pharmaceutical Co., Ltd.
I. Project name
Biological medicine industrialization base construction project of Shandong Shennuoji Pharmaceutical Co., Ltd.
II. Briefings of project unit
The company was established on January 10, 2012 with registered capital of 10 million Yuan. The company is established by Beijing Shenaoji Pharmaceutical Co., Ltd. and is mainly engaged in industrial production of Class I original new drugs. Currently, the company is promoting industrialization of Icaritin crude drug and their products belong to national Class I new anti-tumor drugs which have significant effect on restraining mammary cancer, endometrial carcinoma and liver cancer cells. Meanwhile, the company is also taking an active participate in semi-work production and industrialization of new anti-tumor chemical synthesis drugs, diagnostic reagent, monoclonal antibody and other national Class I new drugs.
III. Project contents and construction capacity
The project mainly constructs extraction workshop, R&D and semi-work production workshop, power plant, warehouse and other facilities with construction area of 56,570 m2 and purchases 276 sets of equipments, such as stainless steel retort, reaction kettle and auto-control system.
IV. Project construction conditions
The project is located in the south of Huihe Avenue, Laicheng Industrial Park, Laiwu City and in the east of South Zhuhai Road. Necessary formalities are completely prepared at earlier stage of project and it has already matched construction conditions.
V. Total investment
USD 280 million
VI. Market forecast and analysis
After being put into full operation, the project is planning to annually produce 1,500 kg Icaritin crude drugs, newly increase sales revenue of 3 billion Yuan and realize profit of 800 million Yuan.
VII. Way of cooperation
Joint venture and cooperative operation
VIII. Contact information
Contact person: Wei Zhenyu
Telephone & Fax: 0086-13963405357
E-mail: weizhenyu@163.com